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Abstract
Background: Actinobacillus pleuropneumoniae (APP) is one of the most important swine pathogens worldwide.
Identification and characterization of novel antigenic APP vaccine candidates are underway. In the present study,
we use an immunoproteomic approach to identify APP protein antigens that may elicit an immune response in
serotype 1 naturally infected swine and serotype 1 virulent strain S259-immunized rabbits.
Results: Proteins from total cell lysates of serotype 1 APP were separated by two-dimensional electrophoresis
(2DE). Western blot analysis revealed 21 immunoreactive protein spots separated in the pH 4-7 range and 4 spots
in the pH 7-11 range with the convalescent sera from swine; we found 5 immunoreactive protein spots that
separated in the pH 4-7 range and 2 in the pH 7-11 range with hyperimmune sera from S259-immunized rabbits.
The proteins included the known antigens ApxIIA, protective surface antigen D15, outer membrane proteins P5,
subunit NqrA. The remaining antigens are being reported as immunoreactive proteins in APP for the first time, to
our knowledge.
Conclusions: We identified a total of 42 immunoreactive proteins of the APP serotype 1 virulent strain S259 which
represented 32 different proteins, including some novel immunoreactive factors which could be researched as
vaccine candidates.
Background
Actinobacillus pleuropneumoniae (APP) is one of the
most important swine pathogens worldwide. Of the 15
known APP serotypes, serotype 1 is frequently asso-
ciated with a range of lung diseases, including fibrinous,
hemorrhagic pneumonia, and necrotizing pneumonia.
High mortality has been reported in acutely infected
pigs and persistent lung lesions have been observed in
chronically infected pigs [1].
To control APP pathogenesis, several types of vaccines
have been developed that offer various degrees of pro-
tection. The traditional chemically-[2,3], genetically-,
and irradiation-inactivated [4] whole cell vaccines used
thus far have been shown to provide protection against
a homologous challenge from APP, but were ineffective
in staving off infection by different serotypes.
Some cross-serovar protection has been achieved with
live-attenuated vaccines of mutant field isolates, such as
mutant strains of APP serovar 7 [5] and serovar 1 [6,7].
Further development of cross-serovar vaccines would
benefit from a molecular understanding of APP patho-
genesis, which is a complex process involving a number
of different potential virulence factors. The most com-
monly associated virulence factors [8] i.e., ApxI, ApxII,
ApxIII, and ApxIV, have been tested as subunit vaccine
candidates offering potential cross-serovar protection
[9,10]. DNA vaccines encoding multiple Apx toxins
offer a novel strategy for protecting against APP infec-
tion [11]. In addition to Apx toxins, several other APP
proteins have been researched as vaccine candidates,
such as the 48 kDa outer membrane protein [12] and
the 30 kDa membrane protein of the ABC transporter
family [13]. Lipopolysaccharide (LPS)-based vaccines are
alternative to protein antigens [14].
The identification of novel antigens as candidate vac-
cines should be accelerated by modern technologies.
The complete genomes of APP L20 (Serotype 5b [15])
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outer membrane proteome of serotype 5b has also been
characterized [17]. In this paper, we use an immunopro-
teomic approach to identify APP protein antigens that
elicit an immune response in serotype 1 naturally
infected swine and serotype 1 virulent strain S259-
immunized rabbits. This approach, which we have used
to study immunogenicity of other bacterial pathogens
[18], combines the specificity of antibody detection with
the precision of mass spectral analysis [19] for identify-
ing antigenic bacterial proteins.
Results
Two-dimensional electrophoresis (2DE) profiles of APP
bacterial proteins and western blot analysis
Proteins from total cell lysates of APP serotype 1 were
separated by 2DE. Two-dimensional separation profiles
are shown for separation by isoelectric point (pI)i n
the first dimension over a pH ranges of pH 4-7
(Figures 1A, 2A) and pH 7-11 (Figures 3A, 4A). The
separation profiles were highly reproducible in 2DE
experiments conducted in triplicate followed by mem-
brane transfer and developing, yielding similar patterns
of total proteins and immunoreactive proteins. Figures
1B, 2B, 3B and 4B show the western blot analysis with
the convalescent sera from naturally infected APP
serotype 1 swine and from hyperimmune sera from
S259-immunized rabbit. No specific immunoreactive
protein spots were observed when negative control
sera were used.
Alignment of total protein and immunoreactive protein
images
Comparisons between 2DE gels and western blot mem-
branes were very difficult to make because only a por-
tion of the proteins on the transferred membrane were
immunoreactive and the sensitivity of the western blot
was higher than that of Coomassie brilliant blue. In this
study, we overcame this challenge by using the layer
function of PhotoshopCS to compare western blot and
2DE gels with the ponceaus S stain as an intermediate
state. The same membranes used for western blots were
also stained with Ponceau S to visualize all proteins.
Digital images of the western blots and Ponceau S-
stained membranes were compared with the 2DE gels
by aligning the images with the layer function of Photo-
shop CS (Additional file 1, Figure S1, Additional file 2,
Figure S2, Additional file 3, Figure S3, Additional file 4,
Figure S4). Using this method to align developed mem-
branes and 2DE gels in the pH 4-7 range (Figures 1, 2)
and the pH 7-11 range (Figures 3, 4), we found 42
immunoreactive protein spots that represented 32 differ-
ent proteins. The identified spots were labeled on each
gel (Figures 1, 2, 3 and 4).
Identification of immunoreactive proteins
A total of 42 immunoreactive proteins were identified
by immunoproteomics. Corresponding spots for immu-
noreactive proteins were excised from preparative 2DE
gels, subjected to tryptic digestion, and analyzed by
mass spectrometry and peptide mass fingerprinting
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Figure 1 Comparison of western blot analysis with convalescent sera from swine and duplicated gels of S259 bacterial associated
proteins at pH 4-7. A. Coomassie G-250-stained 2DE gel. All identified protein spots were analyzed by MALDI-TOF MS. B. Western blot analysis
of proteins on 2DE gel as transferred to a PVDF membrane. The primary antibodies were convalescent sera from swine naturally infected with
APP serotype 1.
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Page 2 of 11(PMF). For conclusive identification of the protein cor-
responding with each spot, the probability score of the
match (Protein scores > 83 were significant), the weight-
average molecular weight (MW), pI, number of peptide
matches, and percentage of the total translated open
reading frame (ORF) sequence covered by the peptides
were analyzed. Descriptive data for the identified spots
are listed in Tables 1 and 2. Only the proteins ranking
first in each matching search are shown. Western blot
analysis with convalescent sera from swine naturally
infected APP serotype 1, led us to identify 32 immunor-
eactive spots, representing 25 proteins, including 21 that
separated in the pH 4-7 range (Figure 1) and 4 that
separated in the pH 7-11 range (Figure 3). Western blot
analysis with hyperimmune sera raised in an S259-
immunized rabbit revealed 10 immunoreactive spots
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Figure 2 Comparison of western blot analysis with rabbit hyperimmune sera and duplicated gels of S259 bacterial associated
proteins at pH 4-7. B. A. Coomassie G-250-stained 2DE gel. All identified protein spots were analyzed by MALDI-TOF MS. B. Western blot
analysis of proteins on 2DE gel as transferred to a PVDF membrane. The primary antibodies were hyperimmune sera from S259-immunized
rabbits.
APBs4 APBs6
APBs1
APBs5
APBs2 APBs3
APBs7
APBs8
APBs9
APBs3 APBs2 APBs1
APBs8
APBs7
APBs4 APBs5 APBs6
pH7 pH7 pH11 pH11
A B
148
98
64
50
36
16
6
Figure 3 Comparison of western blot analysis with convalescent sera from swine and duplicated gel of S259 bacterial associated
proteins at pH 7-11. C. A. Coomassie G-250-stained 2DE gel. All identified protein spots were analyzed by MALDI-TOF MS. B. Western blot
analysis of proteins on 2DE gel as transferred to a PVDF membrane. The primary antibodies were convalescent sera from swine naturally infected
with APP serotype 1.
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Page 3 of 11that represented 7 proteins, including 5 that separated
in the pH 4-7 range (Figure 2) and 2 that separated in
the pH 7-11 range (Figure 4).
Bioinformatics analysis
The BLASTX results are shown in Tables 1 and 2. The
single top ranking proteins identified for each spot are
listed in the tables. All identified proteins were predicted
by PSORTb version 3.0 software http://www.psort.org/.
Among the protein spots analyzed with convalescent
sera from swine, 2 proteins were annotated as periplas-
mic proteins, 4 as outermembrane proteins, 1 as an
extracellular protein, 11 as cytoplasmic proteins, 2 as
cytoplasmic membrane proteins, and 5 were unknown.
Meanwhile, in protein spots analyzed with hyperimmune
sera from rabbit, 2 proteins were predicted as outer-
membrane proteins, 4 as cytoplasmic proteins, and 1
was unknown.
Discussion
In this study, a total of 42 immunoreactive spots, repre-
senting 32 different proteins from APP S259 were iden-
tified by western blot analysis with convalescent sera
from swine and hyperimmune sera from rabbits. Four of
those proteins, ApxIIA (spot APs25,26), D15 (spot
APs21,22), subunit NqrA (spot APr12), outer membrane
protein P5 (spot APBs1,2,3,4,5,6,8; APBr1,2 ), have been
demonstrated recently as immunogenic proteins in APP
JL03 [20].
ApxIIA, which belongs to the RTX family [21], has
been reported to be moderately cytotoxic and weakly
hemolytic [22]. Chiang et al. designed DNA vaccines
that encode ApxIA or ApxIIA. The vaccines elicited
humoral immune responses and protective efficacy in
mice [11]. D15 (or its precursor) is an essential com-
ponent of outer membrane biogenesis and outer mem-
brane protein assembly [23,24]. The immunogenicity of
D15 has been demonstrated in both Haemophilus
ducreyi [25] and Pasteurella multocida [26]. Thus, D15
i sah i g h l yc o n s e r v e da n t i g e na n dm a yb eau s e f u l
component of a universal subunit vaccine against Hae-
mophilus infection [27]. Subunit NqrA was identified
as a 48-kDa outer membrane protein with immuno-
genic in serotype 1 or 5A and is common to 12 APP
serotypes, but is not present in related Gram-negative
swine pathogen species [12]. Outer membrane protein
P5 (or its precursor), which is a homolog of OmpA in
Pasteurella trehalosi and Escherichia coli,m a yb e
involved in the adherence of bacteria to nasopharyn-
geal mucin [28].
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Figure 4 Comparison of western blot analysis with rabbit hyperimmune sera and duplicated gels of S259 bacterial associated
proteins at pH 7-11. D. A. Coomassie G-250-stained 2DE gel. All identified protein spots were analyzed by MALDI-TOF MS. B. Western blot
analysis of proteins on 2DE gel as transferred to a PVDF membrane. The primary antibodies were hyperimmune sera from S259-immunized
rabbits.
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Page 4 of 11Table 1 Summary of immunoreactive proteins identified with convalescent sera from swine naturally infected APP serotype 1
Spot
No.
Protein
No.
Protein Identified Theoretical
MW/pI
Experimental
MW/pI
Peptide match (sequence
coverage, %)
PSORTb localization PSORTb
Probability
a
Mowse
score
b
APs1 gi|
307245438
Polyribonucleotide nucleotidyltransferase 77.439/4.96 30.6/6.35 41 (48%) Cytoplasmic 9.97 336
APs2 gi|
190150916
ATP-binding protein 24.383/8.52 40.1/6.50 12 (59%) Unknown 122
APs3 gi|3913235 Chaperonin GroEL (HSP60 family) 57.722/4.90 63.9/4.67 21 (35%) Cytoplasmic 9.97 197
APs4 gi|
126207624
CTP synthetase 60.032/5.70 60.1/4.70 31 (71%) Cytoplasmic 9.97 424
APs5 gi|
190151264
Chaperone protein dnaK 67.899/4.76 43.5/4.74 41 (64%) Cytoplasmic 9.97 389
APs7 gi|
126209221
fumarate hydratase 50.756/6.14 76.2/5.04 23 (43%) Cytoplasmic 9.97 157
APs8 gi|
303252313
bifunctional UDP-sugar hydrolase/5’-nucleotidase periplasmic
precursor
61.029/6.31 61.2/5.08 35 (60%) Periplasmic 9.76 259
APs10 gi|
307245892
Transketolase 2 73.746/5.47 64.2/5.56 36 (42%) Cytoplasmic 9.97 297
APs11 gi|
53728830
Translation elongation factors (GTPases) 77.515/5.10 94.6/5.11 41 (67%) Cytoplasmic 9.97 356
APs12 gi|
46143894
TPR repeat 55.365/9.45 97.6/5.54 28 (62%) Unknown 373
APs13 gi|
46143698
Sugar transferases involved in lipopolysaccharide synthesis 44.335/9.35 97.8/5.52 18 (59%) CytoplasmicMembrane 10 268
APs14 gi|
307245832
hypothetical protein appser1_10340 45.695/6.34 71.7/5.20 18 (55%) Unknown 245
APs15 gi|
303253793
Type I restriction enzyme EcoEI R protein 90.370/6.55 94.1/5.14 40 (59%) Unknown 393
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1Table 1 Summary of immunoreactive proteins identified with convalescent sera from swine naturally infected APP serotype 1 (Continued)
APs16 gi|
307244854
GTP-binding protein typA/bipA 68.343/5.24 69.5/5.26 34 (42%) CytoplasmicMembrane 7.88 284
APs17 gi|
307246005
hypothetical protein appser1_12060 95.894/5.38 94.8/5.36 36 (45%) Cytoplasmic 9.97 322
APs18 43 (54%) 379
APs19 gi|
46143487
Asparagine synthetase A 37.397/5.91 76.1/5.53 21 (65%) Cytoplasmic 10 290
APs20 gi|
53729159
BioD-like N-terminal domain of phosphotransacetylase 77.017/5.50 74.9/5.55 40 (52%) Cytoplasmic 9.97 384
APs21 gi|
126207895
protective surface antigen D15 precursor 89.088/6.30 89.1/6.31 36 (47%) OuterMembrane 10 302
APs22 gi|
307245243
Protective surface antigen D15 89.172/6.30 89.2/6.22 21 (28%) OuterMembrane 10 152
APs23 gi|
303252337
DNA topoisomerase III 72.857/9.07 96.9/5.18 40 (72%) Cytoplasmic 9.97 385
APs25
APs26
gi|
60476777
ApxIIA 102.466/5.50 102.4/5.51
102.4/5.24
32 (35%)
13 (14%)
Extracellular 10 314
117
APBs1
APBs2
APBs3
APBs8
gi|
307246344
Outer membrane protein P5 39.638/9.24 39.5/9.31
39.5/9.25
39.7/9.18
34.9/9.31
26 (72%)
24 (61%)
22 (55%)
28 (72%)
OuterMembrane 10 243
220
229
278
APBs4
APBs5
APBs6
gi|
307246787
Outer membrane protein P5 38.778/9.51 39.2/9.52
39.2/9.56
39.2/9.62
26 (63%)
25 (76%)
30 (68%)
OuterMembrane 10 260
262
289
APBs7 gi|
165976709
ABC-type transport system involved in resistance to organic
solvents, auxiliary component
23.399/9.65 23.4/9.60 14 (34%) Unknown 168
APBs9 gi|
46143830
Periplasmic component of the Tol biopolymer transport
system
44.768/8.97 48.8/8.56 26 (53%) Periplasmic 9.76 310
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1Table 2 Summary of immunoreactive proteins identified with hyperimmune sera raised in an S259-immunized rabbit
Spot
No.
Protein
No.
Protein Identified Theoretical
MW/pI
Experimental
MW/pI
Peptide match (sequence
coverage, %)
PSORTb
localization
PSORTb
Probability
a
Mowse
score
b
APr4 gi|
32034816
Ribosomal protein L7/L12 12.322/4.72 10.8/4.75 10 (99%) Unknown 109
APr8
APr9
gi|
165977457
putative aldehyde dehydrogenase 54.094/5.48 54.4/5.46
54.5/5.44
13 (29%)
26 (48%)
Cytoplasmic 9.26 122
221
APr10
APr11
gi|
165976190
pyruvate dehydrogenase subunit E1 98.894/5.46 98.1/5.50 19 (28%)
45 (53%)
Cytoplasmic 9.97 433
339
Apr12 gi|
53728874
Na+-transporting NADH:ubiquinone oxidoreductase,
subunit NqrA
48.573/5.91 50.9/5.97 26 (63%) Cytoplasmic 9.97 305
Apr14 gi|
32035558
Transaldolase 34.959/ 5.02 37.7/5.03 37 (62%) Cytoplasmic 9.97 117
APBr1
APBr2
gi|
190150781
outer membrane protein P5 precursor 39.588/9.17 39.6/9.28
35.9/9.28
18 (55%) OuterMembrane 10 170
209
APBr3 gi|
32034275
Outer membrane protein and related peptidoglycan-
associated (lipo)proteins
38.708/9.51 38.7/9.53 7 (29%) OuterMembrane 10 94
(a) Localization predictions based on PSORT server http://www.psort.org/ evaluation. The values are localization probabilities (from 0 to 10).
(b) Mowse score is the score based on the mowse algorithm in Mascot http://www.matrixscience.com. Protein scores > 83 are significant (p < 0.05).
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1The ribosomal subunit proteins L7/L12 (spot APr4)
and pyruvate dehydrogenase subunit E1 (Spots APr10,
11) [29] were identified as immunogenic proteins in
members of the Bacillus cereus group [30], but have not
previously been identified as such in APP before.
The remaining 23 proteins identified in our study are
being reported here as immunoreactive proteins for the
first time, to our knowledge. The majority of these
immunoreactive proteins were linked to housekeeping
functions, such as energy production (e.g. spot APr8,
APr9), carbohydrate transport and metabolism (e.g. spot
APs2, APs13), amino acid transport and metabolism (e.
g. APs19), and chaperones (e.g. spot APs3, APs5 ),
reflecting their importance for survival.
We ultimately concluded that the spots labeled as
APs6, APs9 and APr15, APr16 were likely mixtures of
several proteins; there were no corresponding sequences
for these spots available for Mascot searches. Our inabil-
ity to identify these spots can be attributed to several
reasons, including the genome sequence of APP sero-
type 1 being incomplete, the spots not being evident on
duplicated gels, and/or a few adjacent spots being mixed
together.
Highly conserved immunogenic proteins could poten-
tially induce protection against a wide variety of bacter-
ial strains and are thus attractive novel vaccine
candidates. Goure et al. have identified APP genes that
are conserved among all 15 serotypes by comparative
genomic hybridization [31]. Of these conserved genes,
the genes encoding protective surface antigen D15 and
outer membrane protein P5 were observed in our
results. Subunit NqrA was also demonstrated to be
common to 12 serotypes by Cruz et al. [12]. It is notable
that outer membrane protein APBr3 was also found in
different APP serotypes and showed a high level of con-
servation across serotypes.
The reliability of our protein identification was further
confirmed by comparison of the experimental MW and
pI values of the protein spots on the 2DE gels with the
theoretical ones. Overall, the majority of the theoretical
and experimental values matched well, though some dis-
crepancies remained. Similar migration for several pro-
teins has previously been described in proteomic
analysis of serotype 3 APP [20] and other pathogens
[32,33]. The presence of natural isoforms, post-transla-
tional proteolytic processing and/or modification, or
artifacts related to sample preparation might explain the
discrepancies. In addition, 7 proteins were identified
from more than one position on the gels, including
outer membrane protein P5, perhaps due to the pre-
sence of horizontal isoforms.
Different western blot results were obtained with ana-
lyses from swine versus rabbit sera. Only one common
protein in the two species (outer membrane protein P5)
was identified. Further research is needed to illuminate
the factors that may explain this divergence.
Conclusions
We optimized 2DE sample preparation for APP, and
obtained clearly visualized 2DE profiles with abundant
spots. This method can applied in proteome studies of
other Gram-negative bacteria. Using this approach, we
identified 32 proteins by western blot analysis using
convalescent sera from swine and hyperimmune sera
from rabbits. The newly identified immunoreactive APP
serotype 1 proteins are of great interest in terms of
understanding pathogen-host interaction and can be
considered novel vaccine candidates.
Methods
Strain and culture conditions
APP virulent strain S259 was purchased from the Con-
trol Institute of Veterinary Bioproducts and Pharmaceu-
ticals of China. The cells were cultured in Trypticase
Soy Broth (TSB, Merck, Germany); nicotinamide ade-
nine dinucleotide (NAD, Sinopharm, Shanghai, China)
was added to the medium at a final concentration of
0.01%. One-hundred-milliliter cultures were shaken
overnight at 37°C on a rotary incubation shaker running
at 180 rpm until they reached the late stage of exponen-
tial phase. Cells were harvested by centrifugation at
10,000 ×g for 10 min at 4°C and washed three times
with phosphate buffered saline (PBS).
Sera
Convalescent serum from swine naturally infected with
APP serotype 1 were screened by two steps. Step 1,
seeking convalescent sera against APP. A total of 769
swine serum samples were collected from 29 herds in
different provinces of China in 2009. Then ApxIV-
ELISA was performed to screen convalescent serum
from naturally infections as reported previously [34].
The ApxIV-ELISA has the advantage over other serolo-
gical tests that it does not show cross-reactions with
other bacterial species and that it is highly sensitive and
allows also the serological detection of pigs infected by
the different serotypes of APP or carrying the agent
without apparent clinical signs or symptoms of infec-
tion. Furthermore the test allows clear differentiation
between pigs infected with APP and healthy pigs that
were vaccinated against APP. In addition, we have
traced the background of corresponding swine. These
swine were never immunized any vaccines against APP
infection and were apparently healthy. Step 2, seeking
convalescent sera against APP serotype 1 with S259
whole cell ELISA as described elsewhere [18]. As nega-
tive controls, we tested sera from newly born piglets
using the same methods.
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Page 8 of 11To prepare hyperimmune serum, rabbits were immu-
nized with formaldehyde-inactivated APP S259 vaccine,
with Montanide ISA 206 VG (SEPPIC, France) used as
an adjuvant. Two doses of 1.0 × 10
9 cells/rabbit were
administered by intramuscular injections with a 3-week
interval. Sera from negative control and immunized rab-
bits were collected before the first and after the second
immunization. Serum titers were evaluated with S259
whole cell ELISA.
Our experimental research has been performed with
the approval of Institute of Veterinary Medicine, Jiangsu
Academy of Agricultural Sciences(SYXK 2010-0005)
Protein sample extraction
Washed APP S259 cell pellets were re-suspended in 5-
mL sample preparation solutions (7 M urea, 2 M
thiourea, 4% w/v CHAPS, and 40 mM DTT) and soni-
cated in an ice bath for 50 cycles (5 s on, 10 s off) at a
power setting of 200 W. The cell lysate was incubated
for 30 min at 25°C to solubilize proteins (vortexing
every 10 min) and centrifuged at 10,000 ×g for 20 min
at 25°C to pellet the insoluble components. To precipi-
tate proteins, the cleared supernatants were treated with
pre-chilled 100% trichloroacetic acid (TCA) to a final
concentration of 10% and incubated in ice water for 30
min. Precipitated protein was collected by centrifugation
at 10,000 ×g for 10 min at 25°C and washed twice with
pre-chilled acetone. The final pellet was air-dried.
Isoelectric focusing (IEF)
The dried pellet was dissolved in sample preparation
solution, then incubated for 30 min at 25°C (vortexing
every 10 min) and centrifuged at 10,000 ×g for 20 min
at 25°C. Before rehydration, the supernatant was trea-
ted with a 2-D Clean-up Kit (GE Healthcare, Shanghai,
China) to remove contaminants that interfere with IEF.
Then IEF was performed using the Ettan IPGphor 3
IEF system (GE Healthcare, Shanghai, China) with 13-
cm (Immobiline DryStripk, pH 4-7; GE Healthcare,
Shanghai, China) as well as 7-cm (Immobiline Dry-
Strip, pH 7-11; GE Healthcare, Shanghai, China)
immobilized pH gradient (IPG) gel strips. IPG strips
were rehydrated overnight at room temperature with
rehydration solution [7 M urea, 2 M thiourea, 2% w/
vCHAPS, 0.2% w/vDTT, 0.5% v/vIPG buffer (same
range as the IPG strip), and 0.002% w/v bromophenol
blue]. Each of the 13-cm and 7-cm strips was loaded
with 200 μga n d1 0 0μg of protein, respectively. IEF
was carried out at 20°C for 11.5 h (maximum voltage
of 8,000 V, maximum current of 50 μA/IPG strip, total
28,000 Vh) with 13-cm IPG strips or for 5.5 h (maxi-
mum voltage of 5,000 V, maximum current of 50 μA/
IPG strip, total 22,000 Vh) with 7-cm IPG strips, after
12 h of active rehydration.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE)
Before running SDS-PAGE, each IPG strip was equili-
brated for 15 min with 10 mg/ml DTT and 40 mg/ml
iodoacetamide in equilibration buffer (6 M urea, 75 mM
Tris-HCl pH 8.8, 29.3% v/v glycerol, 2% w/v SDS, 0.002%
w/v bromophenol blue). Each IPG strip plus an SDS-
PAGE molecular weight standard (Invitrogen, Shanghai,
China) was loaded on a 12% polyacrylamide gel and
sealed with 1% agarose. Electrophoresis was performed at
15°C at an initial voltage of 110 V for 30 min, followed by
220 V until the tracking dye reached the gel bottom.
Pairs of gels were run simultaneously, one for Coomassie
G-250 stain and the other for western blot analysis. Each
IEF/SDS-PAGE experiment was repeated three times.
Western blot analysis
Protein samples from SDS-PAGE gels were transferred
onto PVDF membranes (GE Healthcare, Shanghai,
China) using a semi-dry blotting apparatus (TE77, GE
Healthcare, Shanghai, China) for 2 h at 0.65 mA/cm
2.
Membrane-bound proteins were detected by staining
with Ponceau S. Briefly, the PVDF membranes were sub-
merged in Ponceau S stain solution (0.1% w/v Ponceau S,
5% v/v acetic acid) with gentle agitation for 5 min. The
membranes were washed several times with distilled
water (dH2O) until the protein spots were visible; the
Ponceau S-stained membranes were digitally scanned
with a Umax scanner (TE77, GE Healthcare, Shanghai,
China). Ponceau S stain was removed by rinsing the
membranes in dH2O with gentle agitation. After remov-
ing Ponceau S, the membranes were blocked with 5% w/
v skim milk in 50 mM Tris-HCl buffer (pH 7.4) contain-
ing 0.05% Tween 20 (TBST) for 2 h at room temperature.
The blocked-membrane was then incubated with conva-
lescent sera from swine or hyperimmune sera from rabbit
at room temperature for 2 h (1:1000 dilution with block-
ing buffer) and then washed three times with TBST for
15 min per wash. The membranes were incubated with
Staphylococcal protein A labeled with horseradish perox-
idase (Boster, Wuhan, China) which has been widespread
applied as one kind of broad-spectrum secondary antibo-
dies of most mammalian species [35-38] at room tem-
perature for 1 h (1:10000 dilution with blocking buffer),
washed three times with TBST, and developed by adding
3,3’-Diaminobenzidine (Tiangen, Beijing, China) until the
optimum color was obtained. For each sample, the wes-
tern blot was repeated three times.
Alignment of total and immunoreactive protein images
Digital images of PVDF membranes stained with Pon-
ceau S and immunoblotting analysis with sera from
swine and rabbit were aligned using the layer function
of Photoshop CS (Adobe). The corresponding protein
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http://www.proteomesci.com/content/9/1/32
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The Ponceau S-stained image was also compared with
the duplicated gel.
Matrix Assisted Laser Desorption Ionization Time-of-Flight
Mass Spectrometry (MALDI-TOF MS) and database
searches
Immunoreactive proteins in the western blots were identi-
fied and excised from a duplicate SDS-PAGE gels and sent
to Nanjing Ji’ao BioTechnologies Co., Ltd for in-gel trypsin
digestion and MALDI-TOF MS. PMF data were analyzed
using the MASCOT server http://www.matrixscience.com.
In MASCOT searches, protein scores > 83 were significant
(p < 0.05). The protein scores as well as the original PMF
data such as extent of sequence coverage, number of pep-
tides matched were used to accept protein identifications.
The remaining proteins with scores < 83 were either veri-
fied manually or rejected.
Bioinformatics analysis
Sequences of the identified proteins were searched in
the BLASTX server http://blast.ncbi.nlm.nih.gov/ to find
homologous sequences and searched in the PSORT ser-
ver http://www.psort.org/ to predict protein subcellular
localization.
Additional material
Additional file 1: Figure S1. Comparison of western blot analysis
with swine convalescent sera and ponceaus S stain, as an
intermediate state, at pH 4-7. In Photoshop, the immunoblot was used
as the background layer and ponceaus S stain as the surface layer. The
0%, 20%, 40%, 60%, 80% and 100% transparency data are shown in A, B,
C, D, E and F, respectively.
Additional file 2: Figure S2, Comparison of western blot analysis
with rabbit hyperimmune sera and ponceaus S stain, as an
intermediate state, at pH 4-7. In Photoshop, the immunoblot was used
as the background layer and ponceaus S stain as the surface layer. The
0%, 20%, 40%, 60%, 80% and 100% transparency data are shown in A, B,
C, D, E and F, respectively.
Additional file 3: Figure S3. Comparison of western blot analysis
with swine convalescent sera and ponceaus S stain, as an
intermediate state, at pH 7-11. In Photoshop, the immunoblot was
used as the background layer and ponceaus S stain as the surface layer.
The 0%, 20%, 40%, 60%, 80% and 100% transparency data are shown in
A, B, C, D, E and F, respectively.
Additional file 4: Figure S4. Comparison of western blot analysis
with rabbit hyperimmune sera and ponceaus S stain, as an
intermediate state, at pH 7-11. In Photoshop, the immunoblot was
used as the background layer and ponceaus S stain as the surface layer.
The 0%, 20%, 40%, 60%, 80% and 100% transparency data are shown in
A, B, C, D, E and F, respectively.
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